Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
NASDAQ
20.031,13
1,35%
Bitcoin
98.372,49
-0,31%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ AnaptysBio Inc (ANAB) AnaptysBio Inc (ANAB) Notizie

AnaptysBio Inc

ANAB
13,89
-0,08 (-0,57%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 23:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/12/202422:30EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
11/12/202422:06EDGAR2Form 8-K - Current report
11/12/202414:30GLOBEAnaptys Announces Phase 2b Trial of ANB032, a BTLA Agonist,..
15/11/202422:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/11/202415:24EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
05/11/202422:27EDGAR2Form S-3 - Registration statement under Securities Act of..
05/11/202422:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/11/202422:17EDGAR2Form 8-K - Current report
05/11/202422:15GLOBEAnaptys Announces Participation in November and December..
24/9/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202422:16EDGAR2Form 144 - Report of proposed sale of securities
18/9/202400:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202400:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202415:15GLOBEAnaptys Announces Participation in September Investor..
16/8/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202418:07EDGAR2Form SC 13D/A - General Statement of Acquisition of..
16/8/202418:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202422:43EDGAR2Form 8-K - Current report
14/8/202422:41EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/8/202422:34EDGAR2Form 144 - Report of proposed sale of securities
14/8/202411:00GLOBEAnaptys Announces Pricing of $100 Million Underwritten..
05/8/202422:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/8/202422:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/8/202422:18EDGAR2Form 8-K - Current report
05/8/202422:15GLOBEAnaptys Announces Second Quarter 2024 Financial Results and..
24/7/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202402:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202422:09EDGAR2Form 144 - Report of proposed sale of securities
19/6/202402:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/6/202402:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/6/202402:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/6/202402:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/6/202402:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:05EDGAR2Form 8-K - Current report
09/5/202422:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:20EDGAR2Form 8-K - Current report
09/5/202422:15GLOBEAnaptys Announces First Quarter 2024 Financial Results and..
09/5/202422:10GLOBEAnaptys Announces Positive Top-Line GEMINI-2 Phase 3..
09/5/202422:05GLOBEAnaptys to Receive $50 Million in a Capped Non-Recourse..
06/5/202418:59EDGAR2Form SC 13G - Statement of acquisition of beneficial..
24/4/202415:00PRNUSActym Therapeutics Appoints Thomas Smart as CEO
11/3/202421:41EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/3/202421:36EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/3/202421:19EDGAR2Form 8-K - Current report
29/2/202415:15GLOBEAnaptys to Present at TD Cowen’s 44th Annual Health Care..
14/2/202416:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202415:15GLOBEAnaptys to Present at Guggenheim’s 6th Annual Biotechnology..
10/1/202401:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 13,91 Min: 13,82 Max: 14,59
Chiusura: 13,97

La tua Cronologia

NASDAQ
ANAB
AnaptysBio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network